XML 57 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity:
Number of SharesWeighted-Average Exercise Price
(per share)
Weighted-Average Remaining
Contractual
Life
(in years)
Aggregate Intrinsic Value
(in thousands)
Options outstanding as of March 31, 2023
6,950,436 $12.73 6.12$45,689 
Granted602,491 12.66 
Exercised(1,223,630)3.24 
Forfeited / Expired(531,428)27.42 
Options outstanding as of March 31, 2024
5,797,869 $13.26 5.39$2,423 
Exercisable as of March 31, 2024
4,779,833 $11.64 4.70$2,423 
Schedule of RSU, PSU and RSA Activity
The following table summarizes RSU, PSU, and RSA activity:
Number of SharesWeighted-Average Grant Date Fair Value
Unvested restricted shares outstanding as of March 31, 2023
1,670,589 $24.96 
Granted4,565,093 9.92 
Vested(1,723,149)15.93 
Forfeited(592,691)14.53 
Unvested restricted shares outstanding as of March 31, 2024
3,919,842 $12.44 
Schedule of Market-based Assumptions The assumptions utilized in this model during fiscal years 2024, 2023, and 2022 are presented below.
 Year ended March 31,
 202420232022
Risk-free interest rate
3.82% to 4.29%
2.71% to 4.38%
0.63% to 1.77%
Expected life of the options (years)
4.70 to 4.72
5.27 to 5.33
4.82 to 5.27
Expected volatility
88% to 88%
72% to 80%
72% to 72%
Expected dividend yield—%—%—%
Schedule of Intrinsic Value of Stock Option
Total fair value of options vested and total intrinsic value of options exercised was as follows for the fiscal years presented:
 Year ended March 31,
 202420232022
Total fair value of options vested$12,334 $15,375 $11,495 
Total intrinsic value of options exercised$6,441 $16,909 $68,163